NYSE:FNA - New York Stock Exchange, Inc. - US69913P1057 - Common Stock - Currency: USD
Ever wonder where today's self-made millionaires got their start? It's easy to imagine everyone with wealth was born that way, but sometimes it comes down to raw talent and serious focus. Learn More:...
Leveraging Paragon 28's technology platform, Zimmer enhances its portfolios of fracture and trauma, and joint replacement.
Mentions: ZBH
Zimmer Biomet beat Q4 estimates with $2.02 billion in sales and $2.31 EPS.
Mentions: ZBH
/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the...
Mentions: ZBH
/PRNewswire/ -- Kaskela Law LLC announces that it is investigating the recently announced buyout of Paragon 28, Inc. ("Paragon") (NYSE: FNA) shareholders....
/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2024. The Company...